Home
›
Theravance Biopharma, Inc.
› SCHEDULE 13G/A Feb 17, 2026
Theravance Biopharma, Inc. (TBPH): SCHEDULE 13G/A filed Feb 17, 2026
Form type
SCHEDULE 13G/A
Filing date
Feb 17, 2026
Accession number
0001493152-26-007116
Filer
Theravance Biopharma, Inc.
(CIK 1583107)